New and Exploratory Therapeutic Agents for Asthma

  • Michael Yeadon Zuzana Diamant
€ 67,01
5% studentenkorting Bestel twee verschillende Nederlandstalige boeken en krijg 5% studentenkorting
Bekijk online exemplaar
Discusses three major classes of asthma therapies-bronchodilators, antiinflammatories, and antiallergics-as well as potential new therapeutic approaches! This comprehensive volume addresses the latest treatment strategies for asthma, keying in on the genetics and molecular biology of asthma and pointing the way toward new, commercially viable therapies. Presents the most up-to-date information available on the genetics, epidemiology, pathology, pharmacology, and pulmonology of asthma. Written by more than 20 leading international experts, New and Exploratory Therapeutic Agents for Asthma explores asthma both as incidence of dysfunctional airway smooth muscle and as a disorder of the immune system examines the role of monoclonal antibodies in allergy and asthma describes functions and pharmacokinetic profiles of bronchodilator 2 agonists, anticholinergics, and inhaled glucocorticosteroids investigates the controversy of different types of asthma illustrates the connections between clinical symptoms and the immunopathology of eosinophilic inflammation assesses prospects for the development of a successful oral anti-inflammatory therapy, an immunomodulator that lowers antigen-specific IgE, an anticytokine compound, and an agent that safely combines bronchospasmolytic and anti-inflammatory properties reviews the impact of the recent introduction of antileukotriene agents, clinical findings with PAF antagonists, and selective antimuscarinics evaluates the relationship between improvements in laboratory results and clinical effectiveness and more! Containing over 2000 bibliographic citations and a concise introduction for each chapter, New and Exploratory Therapeutic Agents for Asthma is indispensable for pulmonologists, pediatricians, physiologists, immunologists, allergists, pharmaceutical industry scientists, primary care physicians, and medical s
Epidemiology of Asthma Stephen T. Holgate and A. N. Banik Pathophysiology of Asthma Peter J. Sterk Pathology of Asthma Ratko Djukanovia Muscarinic Receptor Subtypes and Anticholinergic Therapy Allison D. Fryer, Richard W. Costello, and David B. Jacoby Long-Acting 2-Agonist Drugs Richard Beasley, Julian Crane, and Carl Burgess Inhaled Glucocorticoids, Established and New Joseph D. Spahn and Stanley J. Szefler Platelet-Activating Factor Antagonists in Bronchial Asthma Devendra K. Agrawal and Robert G. Townley Tachykinin Receptor Antagonists Guy F. Joos and Charles Advenier Therapeutic Potential of Phosphodiesterase Type 4 Inhibitors in the Treatment of Asthma Bernadette Hughes and Gerry Higgs Leukotriene Modulators Anthony P. Sampson and Zuzana Diamant The Anti-IgE Treatment Strategy for Asthma John V. Fahy Activity of T-Cell Subsets in Allergic Asthma Andre Boonstra and Huub F. J. Savelkoul New Targets for Future Asthma Therapy Peter J. Barnes Current Practice and Future Trends in Clinical Trials in Asthma Johan C. Kips and Romain A. Pauwels
"well-written and thoroughly referenced.provides up-to-date, easy-to-read, and high-quality coverage of new developments in asthma pharmacotherapies.highly recommend[ed]. "-Respiratory Care
Pubyear 2019
ISBN 9780367399252
Verschenen 5 sep. 2019
Omvang 528
Auteur(s) Michael Yeadon Zuzana Diamant
Bindwijze Paperback
Taal Engels
Gerelateerde producten
Kumar and Clark's Clinical Medicine Adam Feather David Randall Mona Waterhouse
Speciale prijs € 64,99 Normale prijs € 74,00
Medizinische Physik in Forschung und Praxis
€ 84,65
MS You Don't Own Me Maria Ann Laver Frank Blaney Michael C. Gonzalez
€ 17,63
€ 67,01
Cellular and Molecular Immunology, 9th revised edition Abul K. Abbas, Andrew H. H. Lichtman, Shiv Pillai
Speciale prijs € 50,99 Normale prijs € 77,50

Scroll to top